A new corticoid for topical therapy. Fluocinolone acetonide.
Sixty-seven patients with chronic and subacute cutaneous lesions of varying long duration that had previously been resistant to topical use of corticosteroid compounds were treated with a cream containing fluocinolone acetonide. To avoid subjective bias, only two classifications were used in appraising results: "complete clearing of treated lesions" and "not effective."Forty-eight patients had complete clearing of the treated area. Results were best in atopic dermatitis, chronic eczematous dermatitis and nummular dermatitis. Granuloma annulare, dyshidrotic dermatitis of the palms and psoriasis were not affected. In some cases in which there were multiple lesions some of the lesions were treated with fluocinolone acetonide cream and some were treated concurrently with other corticoid ointments or with noncorticoid compounds, either bland or with active ingredients. Fluocinolone was effective in more than twice as many cases as the other agents. In some of the patients with chronic disease it was possible to greatly reduce or discontinue systemic steroid therapy after fluocinolone acetonide became available. No untoward effects were observed.
J R
JR
SCHOLTZ
D000287:Administration, Topical; D000305:Adrenal Cortex Hormones; D003876:Dermatitis, Atopic; D003880:Dermatology; D004485:Eczema; D005446:Fluocinolone Acetonide / Q000031:analogs & derivatives; D006801:Humans; D009824:Ointments; D011239:Prednisolone / Q000031:analogs & derivatives; D011565:Psoriasis; D012871:Skin Diseases
D000305:Adrenal Cortex Hormones; D009824:Ointments; D005446:Fluocinolone Acetonide; D011239:Prednisolone; C035394:fluocinolone
DERMATOLOGY; PREDNISOLONE/related compounds